These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29050957)

  • 1. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.
    Wang K; Pearlstein KA; Patchett ND; Deal AM; Mavroidis P; Jensen BC; Lipner MB; Zagar TM; Wang Y; Lee CB; Eblan MJ; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
    Radiother Oncol; 2017 Nov; 125(2):293-300. PubMed ID: 29050957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
    Wang K; Eblan MJ; Deal AM; Lipner M; Zagar TM; Wang Y; Mavroidis P; Lee CB; Jensen BC; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
    J Clin Oncol; 2017 May; 35(13):1387-1394. PubMed ID: 28113017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer.
    Xue J; Han C; Jackson A; Hu C; Yao H; Wang W; Hayman J; Chen W; Jin J; Kalemkerian GP; Matuzsak M; Jolly S; Kong FS
    Radiother Oncol; 2019 Apr; 133():213-219. PubMed ID: 30416046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.
    Dess RT; Sun Y; Matuszak MM; Sun G; Soni PD; Bazzi L; Murthy VL; Hearn JWD; Kong FM; Kalemkerian GP; Hayman JA; Ten Haken RK; Lawrence TS; Schipper MJ; Jolly S
    J Clin Oncol; 2017 May; 35(13):1395-1402. PubMed ID: 28301264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
    Yegya-Raman N; Wang K; Kim S; Reyhan M; Deek MP; Sayan M; Li D; Patel M; Malhotra J; Aisner J; Marks LB; Jabbour SK
    J Thorac Oncol; 2018 Oct; 13(10):1508-1518. PubMed ID: 29883836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
    Vivekanandan S; Landau DB; Counsell N; Warren DR; Khwanda A; Rosen SD; Parsons E; Ngai Y; Farrelly L; Hughes L; Hawkins MA; Fenwick JD
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):51-60. PubMed ID: 28816160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
    Borkenhagen JF; Bergom C; Rapp CT; Klawikowski SJ; Rein LE; Gore EM
    Clin Lung Cancer; 2019 Nov; 20(6):435-441. PubMed ID: 31303452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature.
    Zhang TW; Snir J; Boldt RG; Rodrigues GB; Louie AV; Gaede S; McGarry RC; Urbanic JJ; Daly ME; Palma DA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):582-589. PubMed ID: 30630029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer.
    Schytte T; Hansen O; Stolberg-Rohr T; Brink C
    Acta Oncol; 2010 Oct; 49(7):1058-60. PubMed ID: 20831496
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer.
    Contreras JA; Lin AJ; Weiner A; Speirs C; Samson P; Mullen D; Campian J; Bradley J; Roach M; Robinson C
    Radiother Oncol; 2018 Sep; 128(3):498-504. PubMed ID: 29859754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
    Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
    Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy.
    Lee CC; Zheng H; Soon YY; Foo LL; Koh WY; Leong CN; Vellayappan B; Tey JCS; Tham IWK
    Lung Cancer; 2018 Jun; 120():54-59. PubMed ID: 29748015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
    Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J
    Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
    Hahn E; Jiang H; Ng A; Bashir S; Ahmed S; Tsang R; Sun A; Gospodarowicz M; Hodgson D
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1116-1123. PubMed ID: 28721895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.